Zurcher Kantonalbank (Zurich Cantonalbank) - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 163 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$31,000
+3.3%
26,6930.0%0.00%
Q2 2022$30,000
-62.5%
26,6930.0%0.00%
Q1 2022$80,000
-29.2%
26,693
-37.1%
0.00%
-100.0%
Q4 2021$113,000
-29.4%
42,462
-3.6%
0.00%0.0%
Q3 2021$160,000
-15.3%
44,051
+1.2%
0.00%0.0%
Q2 2021$189,000
+56.2%
43,540
+23.4%
0.00%0.0%
Q1 2021$121,000
-32.8%
35,279
-31.6%
0.00%0.0%
Q4 2020$180,000
+682.6%
51,548
+427.2%
0.00%
Q3 2020$23,000
+27.8%
9,7780.0%0.00%
Q2 2020$18,000
+20.0%
9,7780.0%0.00%
Q1 2020$15,000
-28.6%
9,7780.0%0.00%
Q4 2019$21,000
+16.7%
9,7780.0%0.00%
Q3 2019$18,000
-30.8%
9,7780.0%0.00%
Q2 2019$26,000
+4.0%
9,7780.0%0.00%
Q1 2019$25,000
-41.9%
9,778
-47.7%
0.00%
Q4 2018$43,000
-28.3%
18,6950.0%0.00%
-100.0%
Q3 2018$60,000
+66.7%
18,695
+47.8%
0.00%
Q2 2018$36,00012,6530.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
CM Management, LLC 1,500,000$1,620,0001.72%
Soleus Capital Management, L.P. 14,803,015$15,987,2561.48%
ARMISTICE CAPITAL, LLC 17,136,000$18,506,8800.28%
SPHERA FUNDS MANAGEMENT LTD. 1,228,126$1,326,3760.24%
GSA CAPITAL PARTNERS LLP 971,441$1,0490.09%
NJ State Employees Deferred Compensation Plan 200,000$216,0000.03%
Providence Wealth Advisors, LLC 27,500$29,0130.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 1,151,765$1,243,9060.03%
XTX Topco Ltd 164,238$177,3770.03%
JACOBS LEVY EQUITY MANAGEMENT, INC 3,369,076$3,638,6020.02%
View complete list of RIGEL PHARMACEUTICALS INC shareholders